Sebastian Böttcher, MD

Clinic for Internal Medicine III (Hematology, Oncology, Palliative Care), Rostock University Medical School, Germany

Poster(s):

• 1515 - Re-Treatment with Venetoclax-Obinutuzumab after time-limited, MRD-guided Venetoclax-Obinutuzumab: final analysis of 7 patients with chronic lymphatic leukemia (CLL) treated in the CLL2-BAG trial of the GCLLSG.